Levoketoconazole | Interleukin Related interleukin-related.com

Product Name :
Levoketoconazole

Search keywords :
Cytochrome P450

drugId :
null

Target Vo:
Steroid 11-beta-hydroxylase

Target Vo Short Name :
CYP11B1

Moa_Name:
Steroid 11-beta-hydroxylase inhibitors

First Approval Country :
United States

First Approval Date Filter:
2021

Origin Company_Name :
Strategia Therapeutics

Active Company_Name :
Cortendo Ab

Active Indication_Name:
Cushing Syndrome

In Active Indication_Name:
Diabetes Mellitus, Type 2

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Bemarituzumab Cancer
Simlukafusp alfa site
RFP Tag Antibody (YA882): RFP Tag Antibody (YA882) is an unconjugated, mouse-derived, anti-RFP Tag (YA882) monoclonal antibody. RFP Tag Antibody (YA882) can be used for: WB expriments in species-independent background without labeling.

Author: Interleukin Related

Related Posts